Related references
Note: Only part of the references are listed.Structure of pathological TDP-43 filaments from ALS with FTLD
Diana Arseni et al.
NATURE (2022)
ALS monocyte-derived microglia-like cells reveal cytoplasmic TDP-43 accumulation, DNA damage, and cell-specific impairment of phagocytosis associated with disease progression
Hazel Quek et al.
JOURNAL OF NEUROINFLAMMATION (2022)
Serum naturally occurring anti-TDP-43 auto-antibodies are increased in amyotrophic lateral sclerosis
Elisa Conti et al.
SCIENTIFIC REPORTS (2021)
TDP-43-specific Autoantibody Decline in Patients With Amyotrophic Lateral Sclerosis
Anne Kallehauge Nielsen et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2021)
TDP-43 and HERV-K Envelope-Specific Immunogenic Epitopes Are Recognized in ALS Patients
Elena Rita Simula et al.
VIRUSES-BASEL (2021)
Brain Disposition of Antibody-Based Therapeutics: Dogma, Approaches and Perspectives
Aida Kouhi et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Microglial lysosome dysfunction contributes to white matter pathology and TDP-43 proteinopathy in GRN-associated FTD
Yanwei Wu et al.
CELL REPORTS (2021)
A role for SUMOylation in the Formation and Cellular Localization of TDP-43 Aggregates in Amyotrophic Lateral Sclerosis
Cindy Maurel et al.
MOLECULAR NEUROBIOLOGY (2020)
TDP-43 α-helical structure tunes liquid-liquid phase separation and function
Alexander E. Conicella et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Prevalence and Clinical Phenotype of Quadruple Misfolded Proteins in Older Adults
Shama Karanth et al.
JAMA NEUROLOGY (2020)
TDP-43 real-time quaking induced conversion reaction optimization and detection of seeding activity in CSF of amyotrophic lateral sclerosis and frontotemporal dementia patients
Carlo Scialo et al.
BRAIN COMMUNICATIONS (2020)
Virus-mediated delivery of antibody targeting TAR DNA-binding protein-43 mitigates associated neuropathology
Silvia Pozzi et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
Tau and TDP-43 proteinopathies: kindred pathologic cascades and genetic pleiotropy
Yevgen Chornenkyy et al.
LABORATORY INVESTIGATION (2019)
Cytoplasmic TDP-43 De-mixing Independent of Stress Granules Drives Inhibition of Nuclear Import, Loss of Nuclear TDP-43, and Cell Death
Fatima Gasset-Rosa et al.
NEURON (2019)
The debated toxic role of aggregated TDP-43 in amyotrophic lateral sclerosis: a resolution in sight?
Rudolf C. Hergesheimer et al.
BRAIN (2019)
Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group report
Peter T. Nelson et al.
BRAIN (2019)
The Pathobiology of TDP-43 C-Terminal Fragments in ALS and FTLD
Britt A. Berning et al.
FRONTIERS IN NEUROSCIENCE (2019)
Cryo-EM structures of four polymorphic TDP-43 amyloid cores
Qin Cao et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2019)
The basis of clinicopathological heterogeneity in TDP-43 proteinopathy
Ito Kawakami et al.
ACTA NEUROPATHOLOGICA (2019)
TDP-43 extracted from frontotemporal lobar degeneration subject brains displays distinct aggregate assemblies and neurotoxic effects reflecting disease progression rates
Florent Laferriere et al.
NATURE NEUROSCIENCE (2019)
A single N-terminal phosphomimic disrupts TDP-43 polymerization, phase separation, and RNA splicing
Ailin Wang et al.
EMBO JOURNAL (2018)
TDP-43 post-translational modifications in health and disease
Emanuele Buratti
EXPERT OPINION ON THERAPEUTIC TARGETS (2018)
Towards a TDP-43-Based Biomarker for ALS and FTLD
Emily Feneberg et al.
MOLECULAR NEUROBIOLOGY (2018)
Microglia-mediated recovery from ALS-relevant motor neuron degeneration in a mouse model of TDP-43 proteinopathy
Krista J. Spiller et al.
NATURE NEUROSCIENCE (2018)
Atomic structures of TDP-43 LCD segments and insights into reversible or pathogenic aggregation
Elizabeth L. Guenther et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2018)
Atomic structures of TDP-43 LCD segments and insights into reversible or pathogenic aggregation
Elizabeth L. Guenther et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2018)
Elimination of TDP-43 inclusions linked to amyotrophic lateral sclerosis by a misfolding-specific intrabody with dual proteolytic signals
Yoshitaka Tamaki et al.
SCIENTIFIC REPORTS (2018)
Patient-derived frontotemporal lobar degeneration brain extracts induce formation and spreading of TDP-43 pathology in vivo
Silvia Porta et al.
NATURE COMMUNICATIONS (2018)
TDP-43 Depletion in Microglia Promotes Amyloid Clearance but Also Induces Synapse Loss
Rosa C. Paolicelli et al.
NEURON (2017)
Truncation of the TAR DNA-binding protein 43 is not a prerequisite for cytoplasmic relocalization, and is suppressed by caspase inhibition and by introduction of the A90V sequence variant
Heike J. Wobst et al.
PLOS ONE (2017)
A human microglia-like cellular model for assessing the effects of neurodegenerative disease gene variants
Katie J. Ryan et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
Functional and dynamic polymerization of the ALS-linked protein TDP-43 antagonizes its pathologic aggregation
Tariq Afroz et al.
NATURE COMMUNICATIONS (2017)
Expansion of the classification of FTLD-TDP: distinct pathology associated with rapidly progressive frontotemporal degeneration
Edward B. Lee et al.
ACTA NEUROPATHOLOGICA (2017)
C9orf72 is required for proper macrophage and microglial function in mice
J. G. O'Rourke et al.
SCIENCE (2016)
ALS Mutations Disrupt Phase Separation Mediated by α-Helical Structure in the TDP-43 Low-Complexity C-Terminal Domain
Alexander E. Conicella et al.
STRUCTURE (2016)
Functional recovery in new mouse models of ALS/FTLD after clearance of pathological cytoplasmic TDP-43
Adam K. Walker et al.
ACTA NEUROPATHOLOGICA (2015)
TDP-43 is intercellularly transmitted across axon terminals
Marisa S. Feiler et al.
JOURNAL OF CELL BIOLOGY (2015)
An acetylation switch controls TDP-43 function and aggregation propensity
Todd J. Cohen et al.
NATURE COMMUNICATIONS (2015)
Disease origin and progression in amyotrophic lateral sclerosis: an immunology perspective
Andrea Malaspina et al.
INTERNATIONAL IMMUNOLOGY (2015)
Molecular and cellular neuroinflammatory status of mouse brain after systemic lipopolysaccharide challenge: importance of CCR2/CCL2 signaling
Julie Cazareth et al.
JOURNAL OF NEUROINFLAMMATION (2014)
Stages of pTDP-43 Pathology in Amyotrophic Lateral Sclerosis
Johannes Brettschneider et al.
ANNALS OF NEUROLOGY (2013)
Prion-like Properties of Pathological TDP-43 Aggregates from Diseased Brains
Takashi Nonaka et al.
CELL REPORTS (2013)
Molecular analysis and biochemical classification of TDP-43 proteinopathy
Hiroshi Tsuji et al.
BRAIN (2012)
A role for calpain-dependent cleavage of TDP-43 in amyotrophic lateral sclerosis pathology
Takenari Yamashita et al.
NATURE COMMUNICATIONS (2012)
Dysregulation of the ALS-associated gene TDP-43 leads to neuronal death and degeneration in mice
Lionel M. Igaz et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Novel Types of Frontotemporal Lobar Degeneration: Beyond Tau and TDP-43
Ian R. A. Mackenzie et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2011)
Guidelines for preclinical animal research in ALS/MND: A consensus meeting
Albert C. Ludolph et al.
AMYOTROPHIC LATERAL SCLEROSIS (2010)
TDP-43 Proteinopathy and Motor Neuron Disease in Chronic Traumatic Encephalopathy
Ann C. McKee et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2010)
Multiplex SILAC Analysis of a Cellular TDP-43 Proteinopathy Model Reveals Protein Inclusions Associated with SUMOylation and Diverse Polyubiquitin Chains
Nicholas T. Seyfried et al.
MOLECULAR & CELLULAR PROTEOMICS (2010)
Phosphorylation of S409/410 of TDP-43 is a consistent feature in all sporadic and familial forms of TDP-43 proteinopathies
Manuela Neumann et al.
ACTA NEUROPATHOLOGICA (2009)
Molecular Neuropathology of TDP-43 Proteinopathies
Manuela Neumann
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2009)
Liposomal vaccines with conformation-specific amyloid peptide antigens define immune response and efficacy in APP transgenic mice
Andreas Muhs et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis
Tetsuaki Arai et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis
Manuela Neumann et al.
SCIENCE (2006)
A systematic analysis of the silencing effects of an active siRNA at all single-nucleotide mismatched target sites
Q Du et al.
NUCLEIC ACIDS RESEARCH (2005)
Share Paper
